Diagnosis
Menopause Blood Tests — Are They Useful?
When FSH and other blood tests help, when they mislead, and what NICE actually recommends.
Blood tests are often unnecessary to diagnose menopause. NICE guidance is clear about when tests are appropriate — particularly for women under 45 or with atypical symptoms — and when a symptom-based diagnosis is better.
Very few areas in menopause medicine cause more confusion than blood tests. Patients arrive in clinic clutching private FSH, oestradiol and 'hormone panel' results — often expensive, often unhelpful and sometimes actively misleading. NICE NG23 is unambiguous: in most women over 45, menopause is a clinical diagnosis based on symptoms alone. Blood tests have a real role, but a much narrower one than the direct-to-consumer testing industry suggests. Understanding when they help — and when they can send you down the wrong path — saves months of confusion.
When blood tests are genuinely useful
- Women under 40 with menopausal symptoms — Premature Ovarian Insufficiency (POI) must be excluded with two FSH readings 4–6 weeks apart.
- Women aged 40–45 with symptoms and irregular periods — a supporting FSH can help but is not required.
- Women on Mirena or with a hysterectomy who no longer have a bleeding pattern to guide diagnosis.
- Atypical presentations — for example weight loss, night sweats without flushes, or symptoms in a very young woman — where thyroid disease, autoimmune conditions or other causes need excluding.
- Testosterone therapy — a baseline total testosterone and SHBG are required before starting, and repeated at 3 months.
Why FSH is so unreliable in perimenopause
- In perimenopause, FSH fluctuates dramatically from week to week — a single test rarely reflects your true hormonal status.
- A normal FSH does not rule out perimenopause; a raised FSH does not, on its own, confirm it.
- The combined pill, Mirena, HRT and even acute stress or illness can all skew readings.
- Two readings 4–6 weeks apart give a more reliable picture than any single test.
- Oestradiol levels swing even more than FSH — a single 'low oestrogen' result is almost never actionable in perimenopause.
Tests that ARE worth having
- Thyroid function (TSH, and free T4 if TSH is abnormal) — thyroid disease mimics menopause and is easily missed.
- Ferritin — iron deficiency causes fatigue, hair loss and brain fog that is often blamed on menopause.
- Vitamin D — low levels worsen fatigue, mood and bone health; supplementation is often needed in the UK.
- Vitamin B12 and folate — deficiency mimics brain fog and low mood.
- HbA1c and lipid profile — cardiovascular risk rises after menopause, and a baseline is invaluable.
- Bone density (DXA) — if you have risk factors: early menopause, family history, low BMI, steroid use, or a previous low-trauma fracture.
Tests we generally advise against
- 'Full female hormone panels' offered by online clinics — expensive, rarely change management, and often generate more anxiety than answers.
- Saliva hormone testing — not validated for clinical decision-making in UK menopause practice.
- Repeated FSH testing to 'monitor' HRT — HRT itself alters the numbers; symptoms guide dose changes, not blood levels.
- Anti-Müllerian hormone (AMH) as a menopause test — AMH predicts remaining ovarian reserve but not when you will be symptomatic.
What to bring to a specialist instead of blood tests
- A 4–6 week symptom diary rating sleep, mood, flushes, brain fog and libido on a 0–10 scale.
- A record of your cycle length and heaviness over the past 6–12 months.
- A list of what you've already tried — supplements, over-the-counter remedies, previous prescriptions.
- Your personal and family history — clot, breast cancer, migraine with aura, osteoporosis, cardiovascular disease.
The bottom line
- In women over 45, symptoms — not numbers — decide whether HRT is worth trying.
- In women under 40, blood tests are essential to exclude POI.
- In women 40–45, a good history plus selective blood tests strikes the right balance.
- A specialist consultation joins the dots better than any single blood result.
Key takeaway
The right question is rarely 'what are my hormone levels?' — it is 'what are my symptoms, and what treatment will help?' Selective, targeted blood tests are useful; expensive panels ordered before a proper history are almost never worth it.
How Dr Awal approaches this in clinic
Every consultation starts with your full story — symptoms, cycle, medical history, family history and what you've already tried. From there we look at whether hormonal treatment, non-hormonal options, lifestyle changes or a combination will give you the best result, and we tailor the plan to your age, risk factors and preferences.
- A detailed 60 minute first appointment — no rushed 10-minute slots.
- Evidence-based recommendations aligned with NICE NG23 and BMS guidance.
- Body-identical HRT considered first-line where appropriate.
- Shared-care letters sent to your NHS GP so treatment can continue affordably.
- Follow-up at 3 months to fine-tune your regimen and address side effects.
- Ongoing annual reviews so your plan evolves with you.
Common questions we hear about this
Do I need to be at a certain age to be seen?
No. We see women in early perimenopause (often late 30s and 40s), through post-menopause and beyond. Age alone doesn't decide whether treatment is right — symptoms, health history and goals do.
Will my GP continue the prescription?
In most cases yes. After your consultation we send a detailed shared-care letter with the diagnosis, treatment plan and rationale so your NHS GP can prescribe on the NHS. Not every practice accepts shared care — we'll discuss this in your appointment.
What if I've tried HRT before and it didn't suit me?
Very common — often the type, dose or route wasn't right rather than HRT itself. We review what you've tried, why it didn't work, and adjust accordingly. Many women who thought HRT wasn't for them do well on a different preparation.
How long will I need to stay on treatment?
There is no set upper time limit for HRT. Current BMS and NICE guidance supports continuing HRT for as long as the benefits outweigh the risks for you personally. We review this together every year so you stay in control of the decision.
Where do you see patients?
All consultations at Pause and Co Healthcare are conducted securely via video, allowing us to support patients anywhere in the UK. Prescriptions and shared care arrangements are managed in the same way, regardless of your location.
About the author
Dr Nadira Awal is a British Menopause Society Advanced Menopause Specialist with 15+ years' NHS and private experience. She holds the BMS Advanced Certificate in Menopause Care, sits on the BMS Programme Planning Group, and advises the UK Government Menopause Strategy Group. Read her full profile.
Sources & further reading
General information only — not a substitute for personalised medical advice. Always speak to your GP or a menopause specialist about your own situation.
Talk it through
Book a private consultation with Dr Awal
Get evidence-based, personalised advice on menopause blood tests — are they useful? and any related concerns.